GWG Holdings, Inc. (Nasdaq: GWGH), the parent company of GWG Life, Life Epigenetics and YouSurance, is a leading investor in longevity insurance assets. GWG Life owns longevity risk alternative assets in the form of a portfolio of life insurance policies with $1.96 billion in face value of benefits as of September 30, 2018. Life Epigenetics is commercializing epigenetic technology, while YouSurance is working to offer consumers access to advanced epigenetic technology to reduce the cost of their life insurance. GWGH also has a strategic investment in The Beneficient Company Group, LP, a financial services company providing proprietary liquidity solutions to owners of alternative assets.
Certain information on this Site contains certain forward-looking statements, which are subject to risks and uncertainties and speak only as of the date on which they are made. The words “believe”, “estimate”, “expect”, “target”, “intend”, “may”, “plan” or similar expressions are intended to identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. GWG Holdings undertakes no obligation to update publicly or revise any forward-looking statements. Actual results may differ materially from the expectations disclosed in the forward-looking statements made. Important factors that could cause actual results to differ materially from the company’s forward-looking statements are described in GWG Holdings’ periodic reports, including the Annual Report on Form 10-K, quarterly reports on Form 10-Q and other reports filed with the Securities and Exchange Commission. Please click here to view such factors contained in the latest Form 10-K from GWG Holdings.
GWG files annual, quarterly and current reports, and other information with the SEC. Our SEC filings, including the registration statement of which the Prospectus is a part, and any amendments thereto is available on the SEC’s Internet site at http://www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-877-494-2388.
The information provided herein does not constitute an offer to sell securities or the solicitation of an offer to buy securities. An offer to sell securities can only be made by a Prospectus, pursuant to a registration statement, and any amendments thereto, then effective and on file with the Securities Exchange Commission (“SEC”). Investors must read the entire Prospectus for investment conditions, risk factors, minimum requirements fees and expenses and other pertinent information with respect to the offerings.
Securities are being offered on a best-efforts basis on behalf of GWG by Emerson Equity, LLC, Member FINRA, SIPC, and Managing Broker-Dealer for the Issuer. GWG and Emerson are not affiliated entities.